What is Procter & Gamble's operating income?

Procter & Gamble's total operating income in 2026 was $19.75 billion, based on the following breakdown: Total Gross Profit: $43.67 billion Total Operating Expenses: $23.92 billion

Procter & Gamble (PG) Financials

$143.03 -1.52 (-1.05%)

Closing price 08/17/2026 03:58 PM Eastern

Extended Trading

$143.78 +0.75 (+0.52%)

As of 04:38 AM Eastern

Compare

Annual Income Statements for Procter & Gamble

This table shows Procter & Gamble's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	10,508	15,326	9,750	3,897	13,027	14,306	14,742	14,653	14,879	15,974	16,046
Consolidated Net Income / (Loss)	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065	16,144
Net Income / (Loss) Continuing Operations	10,027	10,194	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065	16,144
Total Pre-Tax Income	13,369	13,257	13,326	6,069	15,834	17,615	17,995	18,353	18,761	20,167	20,377
Total Operating Income	13,441	13,766	13,363	5,487	15,706	17,986	17,813	18,134	18,545	20,451	19,748
Total Gross Profit	32,390	32,420	32,400	32,916	35,700	39,010	38,030	39,246	43,191	43,120	43,670
Total Revenue	65,299	65,058	66,832	67,684	70,950	76,118	80,187	82,006	84,039	84,284	87,032
Operating Revenue	65,299	65,058	66,832	67,684	70,950	76,118	80,187	82,006	84,039	84,284	87,032
Total Cost of Revenue	32,909	32,638	34,432	34,768	35,250	37,108	42,157	42,760	40,848	41,164	43,362
Operating Cost of Revenue	32,909	32,638	34,432	34,768	35,250	37,108	42,157	42,760	40,848	41,164	43,362
Total Operating Expenses	18,949	18,654	19,037	27,429	19,994	21,024	20,217	21,112	24,646	22,669	23,922
Selling, General & Admin Expense	18,949	18,654	19,037	19,084	19,994	21,024	20,217	21,112	23,305	22,669	23,922
Impairment Charge	-	0.00	0.00	8,345	-	-	0.00	0.00	1,341	0.00	0.00
Total Other Income / (Expense), net	-72	-509	-37	582	128	-371	182	219	216	-284	629
Interest Expense	579	465	506	509	465	502	439	756	925	907	877
Interest & Investment Income	182	171	247	220	155	45	51	307	473	469	430
Other Income / (Expense), net	325	-215	222	871	438	86	570	668	668	154	1,076
Income Tax Expense	3,342	3,063	3,465	2,103	2,731	3,263	3,202	3,615	3,787	4,102	4,233
Net Income / (Loss) Attributable to Noncontrolling Interest	96	85	111	69	76	46	51	85	95	91	98
Basic Earnings per Share	$3.80	$5.80	$3.75	$1.45	$5.13	$5.69	$6.00	$6.07	$6.18	$6.67	$6.75
Weighted Average Basic Shares Outstanding	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B	2.32B
Diluted Earnings per Share	$3.69	$5.59	$3.67	$1.43	$4.96	$5.50	$5.81	$5.90	$6.02	$6.51	$6.62
Weighted Average Diluted Shares Outstanding	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B	2.32B
Weighted Average Basic & Diluted Shares Outstanding	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B	2.32B

This table shows Procter & Gamble's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	3,468	3,754	3,136	3,959	4,630	3,769	3,616	4,750	4,319	3,932	3,045
Consolidated Net Income / (Loss)	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781	4,331	3,951	3,081
Net Income / (Loss) Continuing Operations	3,493	3,780	3,145	3,988	4,658	3,793	3,626	4,781	4,331	3,950	3,082
Total Pre-Tax Income	4,496	4,592	3,871	5,140	5,845	4,661	4,521	6,034	5,421	4,989	3,933
Total Operating Income	4,433	4,460	3,885	5,797	5,741	4,558	4,355	5,856	5,366	4,576	3,950
Total Gross Profit	11,297	10,340	10,184	11,316	11,464	10,082	10,258	11,499	11,374	10,513	10,284
Total Revenue	21,441	20,195	20,532	21,737	21,882	19,776	20,889	22,386	22,208	21,235	21,203
Operating Revenue	21,441	20,195	20,532	21,737	21,882	19,776	20,889	22,386	22,208	21,235	21,203
Total Cost of Revenue	10,144	9,855	10,348	10,421	10,418	9,694	10,631	10,887	10,834	10,722	10,919
Operating Cost of Revenue	10,144	9,855	10,348	10,421	10,418	9,694	10,631	10,887	10,834	10,722	10,919
Total Operating Expenses	6,863	5,880	6,299	5,519	5,723	5,524	5,903	5,643	6,008	5,936	6,335
Selling, General & Admin Expense	5,522	5,880	6,299	5,519	5,723	5,524	5,903	5,643	6,008	5,936	6,335
Total Other Income / (Expense), net	62	131	-12	-657	103	104	166	179	55	414	-19
Interest Expense	248	233	219	238	240	217	212	197	220	223	237
Interest & Investment Income	133	104	108	135	119	111	104	108	115	100	107
Other Income / (Expense), net	177	260	99	-554	224	210	274	268	160	537	111
Income Tax Expense	1,003	812	726	1,152	1,187	868	895	1,253	1,090	1,039	851
Net Income / (Loss) Attributable to Noncontrolling Interest	25	27	8.00	28	29	23	11	31	12	18	37
Basic Earnings per Share	$1.44	$1.56	$1.29	$1.65	$1.94	$1.58	$1.50	$2.00	$1.82	$1.66	$1.27
Weighted Average Basic Shares Outstanding	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B	2.32B
Diluted Earnings per Share	$1.40	$1.52	$1.27	$1.61	$1.88	$1.54	$1.48	$1.95	$1.78	$1.63	$1.26
Weighted Average Diluted Shares Outstanding	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B	2.32B
Weighted Average Basic & Diluted Shares Outstanding	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B	2.32B

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Net Change in Cash & Equivalents	266	-2,529	-3,000	1,758	11,942	-5,893	-3,074	1,032	1,235	75	386
Net Cash From Operating Activities	15,435	12,753	14,867	15,242	17,403	18,371	16,723	16,848	19,846	17,817	19,556
Net Cash From Continuing Operating Activities	15,435	12,753	14,867	15,242	17,403	18,371	16,723	16,848	19,847	17,818	19,557
Net Income / (Loss) Continuing Operations	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065	16,144
Consolidated Net Income / (Loss)	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065	16,144
Depreciation Expense	3,078	2,820	2,834	2,824	3,013	2,735	2,807	2,714	2,896	2,847	3,160
Non-Cash Adjustments To Reconcile Net Income	928	-4,434	-1,279	8,495	-31	778	41	722	2,179	-422	-160
Changes in Operating Assets and Liabilities, net	825	-1,044	3,451	-43	1,318	506	-918	-1,326	-202	-672	413
Net Cash From Investing Activities	-5,575	-6,685	-3,511	-3,490	3,045	-2,834	-4,424	-3,500	-3,504	-3,818	-4,624
Net Cash From Continuing Investing Activities	-5,575	-6,210	-3,511	-3,490	3,045	-2,834	-4,424	-3,500	-3,504	-3,818	-4,624
Purchase of Property, Plant & Equipment	-3,314	-3,384	-3,717	-3,347	-3,073	-2,787	-3,156	-3,062	-3,322	-3,773	-4,409
Acquisitions	-186	-16	-109	-3,945	-58	-34	-1,381	-765	-21	-11	-85
Sale of Property, Plant & Equipment	432	571	269	394	30	42	110	46	346	107	508
Sale and/or Maturity of Investments	1,447	1,488	3,955	3,628	6,146	-55	3.00	281	-507	-141	-638
Net Cash From Financing Activities	-9,213	-8,568	-14,375	-9,994	-8,367	-21,531	-14,876	-12,146	-14,855	-14,036	-14,460
Net Cash From Continuing Financing Activities	-9,213	-8,568	-14,375	-9,994	-8,367	-21,531	-14,876	-12,146	-14,855	-14,035	-14,460
Repayment of Debt	-2,631	-4,931	-6,310	-3,184	-14,473	-15,995	-12,904	-18,228	-9,167	-9,627	-10,700
Repurchase of Common Equity	-4,004	-5,204	-7,004	-5,003	-7,405	-11,009	-10,003	-7,353	-5,006	-6,500	-5,028
Payment of Dividends	-7,436	-7,236	-7,310	-7,498	-7,789	-8,263	-8,770	-8,999	-9,312	-9,872	-10,232
Issuance of Debt	3,916	6,330	5,072	2,367	19,322	12,092	14,796	21,165	6,725	10,257	10,593
Other Financing Activities, net	942	2,473	1,177	3,324	1,978	1,644	2,005	1,269	1,905	1,707	907
Other Net Changes in Cash	-	-	19	-	-139	101	-497	-170	-251	-	-86
Cash Interest Paid	569	518	529	497	434	531	451	721	878	896	866

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-1,843	-1,111	2,653	2,675	-1,927	-1,113	440	1,615	-346	1,480	-2,363
Net Cash From Operating Activities	5,100	4,088	5,754	4,302	4,825	3,705	4,985	5,408	4,972	4,045	5,131
Net Cash From Continuing Operating Activities	5,100	4,089	5,754	4,302	4,825	3,704	4,987	5,409	4,972	4,044	5,132
Net Income / (Loss) Continuing Operations	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781	4,331	3,951	3,081
Consolidated Net Income / (Loss)	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781	4,331	3,951	3,081
Depreciation Expense	721	712	761	728	706	690	723	761	802	785	812
Non-Cash Adjustments To Reconcile Net Income	1,735	-442	1,140	-365	80	201	-1,637	-226	-156	-446	668
Changes in Operating Assets and Liabilities, net	-849	38	709	-48	-620	-980	2,275	93	-5.00	-246	571
Net Cash From Investing Activities	-1,002	-762	-518	-1,108	-921	-726	-1,063	-1,535	-1,228	-665	-1,196
Net Cash From Continuing Investing Activities	-1,001	-763	-518	-1,108	-922	-727	-1,061	-1,535	-1,229	-664	-1,196
Purchase of Property, Plant & Equipment	-817	-797	-783	-993	-925	-859	-996	-1,200	-1,167	-1,019	-1,023
Sale of Property, Plant & Equipment	5.00	69	269	45	2.00	17	43	8.00	8.00	485	7.00
Sale and/or Maturity of Investments	-189	-	-4.00	-154	1.00	120	-108	-338	-70	-50	-180
Net Cash From Financing Activities	-6,049	-4,269	-2,499	-634	-5,571	-4,215	-3,616	-2,239	-4,088	-1,827	-6,306
Net Cash From Continuing Financing Activities	-6,052	-4,267	-2,499	-634	-5,570	-4,216	-3,615	-2,237	-4,090	-1,826	-6,307
Repayment of Debt	-3,719	670	-1,640	-1,085	-3,669	-1,048	-3,825	305	-4,580	-3,411	-3,014
Repurchase of Common Equity	-1,003	-987	-1,516	-1,939	-2,510	-1,351	-700	-1,250	-2,278	-625	-875
Payment of Dividends	-2,288	-2,285	-2,449	-2,445	-2,441	-2,433	-2,553	-2,549	-2,544	-2,530	-2,609
Issuance of Debt	873	-2,233	2,166	4,090	2,810	-	3,357	1,123	5,238	4,076	156
Other Financing Activities, net	85	568	940	745	240	616	106	134	74	664	35

This table presents Procter & Gamble's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Total Assets	127,136	120,406	118,310	115,095	120,700	119,307	117,208	120,829	122,370	125,231	126,521
Total Current Assets	33,782	26,494	23,320	22,473	27,987	23,091	21,653	22,648	24,709	25,392	26,208
Cash & Equivalents	7,102	5,569	2,569	4,239	-	10,288	-	8,246	9,482	9,556	9,942
Accounts Receivable	4,373	4,594	4,686	4,951	4,178	4,725	5,143	5,471	6,118	6,185	6,056
Inventories, net	4,716	4,624	4,738	5,017	5,498	5,983	6,924	7,073	7,016	7,550	8,170
Prepaid Expenses	2,653	2,139	2,046	2,218	2,130	2,095	2,372	1,858	2,095	2,100	2,040
Plant, Property, & Equipment, net	19,385	19,893	20,600	21,271	20,692	21,686	21,195	21,909	22,152	23,897	25,360
Total Noncurrent Assets	73,969	74,019	74,390	71,351	72,021	74,530	74,360	76,272	75,508	75,941	74,951
Goodwill	44,350	44,699	45,175	40,273	39,901	40,924	39,700	40,659	40,303	41,650	41,276
Intangible Assets	24,527	24,187	23,902	24,215	23,792	23,642	23,679	23,783	22,047	21,910	21,444
Other Noncurrent Operating Assets	5,092	5,133	5,313	6,863	8,328	9,964	10,981	11,830	13,158	12,381	12,231
Total Liabilities & Shareholders' Equity	127,136	120,406	118,310	115,095	120,700	119,307	117,208	120,829	122,370	125,231	126,521
Total Liabilities	69,153	64,628	65,427	67,516	73,822	72,653	70,354	73,764	71,811	72,946	72,210
Total Current Liabilities	30,770	30,210	28,237	30,011	32,976	33,132	33,081	35,756	33,627	36,058	38,694
Short-Term Debt	11,653	13,554	10,423	9,697	11,183	8,889	8,645	10,229	7,191	9,513	11,296
Accounts Payable	9,325	9,632	10,344	11,260	12,071	13,720	14,882	14,598	15,364	15,227	16,306
Accrued Expenses	7,449	7,024	7,470	9,054	9,722	10,523	9,554	10,929	11,073	11,318	11,091
Total Noncurrent Liabilities	38,383	34,418	37,190	37,505	40,846	39,521	37,273	38,008	38,183	36,889	33,516
Long-Term Debt	18,945	18,038	20,863	20,395	23,537	23,099	22,848	24,378	25,269	24,995	22,842
Noncurrent Deferred & Payable Income Tax Liabilities	9,113	8,126	6,163	6,899	6,199	6,153	6,809	6,478	6,516	5,774	5,760
Other Noncurrent Operating Liabilities	10,325	8,254	10,164	10,211	11,110	10,269	7,616	7,152	6,398	6,120	4,914
Total Equity & Noncontrolling Interests	57,983	55,778	52,883	47,579	46,878	46,654	46,854	47,065	50,559	52,284	54,311
Total Preferred & Common Equity	57,341	55,184	52,293	47,194	46,424	46,308	46,589	46,777	50,286	52,012	54,081
Preferred Stock	1,038	1,006	967	928	800	800	843	819	798	777	756
Total Common Equity	56,303	54,178	51,326	46,266	45,624	45,508	45,746	45,958	49,488	51,235	53,325
Common Stock	67,723	67,650	67,855	67,836	68,203	68,857	69,804	70,565	71,693	72,779	73,542
Retained Earnings	87,953	96,124	98,641	94,918	100,239	106,374	112,429	118,170	123,811	129,973	135,852
Treasury Stock	-82,176	-93,715	-99,217	-100,406	-105,573	-114,973	-123,382	-129,736	-133,379	-138,702	-143,008
Accumulated Other Comprehensive Income / (Loss)	-15,907	-14,632	-14,749	-14,936	-16,165	-13,744	-12,189	-12,220	-11,900	-12,143	-12,465
Other Equity Adjustments	-1,290	-1,249	-1,204	-1,146	-1,080	-1,006	-916	-821	-737	-672	-596
Noncontrolling Interest	642	594	590	385	357	276	265	288	272	272	230

This table presents Procter & Gamble's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	120,829	122,531	120,709	119,598	122,370	126,482	122,639	122,984	127,599	127,286	128,378
Total Current Assets	22,648	24,940	23,111	22,458	24,709	27,449	25,642	24,435	27,118	26,588	27,987
Cash & Equivalents	8,246	-	-	6,828	9,482	12,156	10,230	9,116	11,171	10,825	12,306
Accounts Receivable	5,471	6,215	6,334	6,124	6,118	6,314	6,234	6,139	6,487	6,279	6,322
Inventories, net	7,073	7,117	7,152	7,078	7,016	7,287	7,020	7,400	7,848	7,818	7,853
Prepaid Expenses	1,858	1,875	1,736	2,428	2,095	1,692	2,158	1,780	1,612	1,666	1,506
Plant, Property, & Equipment, net	21,909	21,636	22,132	22,027	22,152	22,506	22,074	22,728	24,119	24,487	24,574
Total Noncurrent Assets	76,272	75,955	75,466	75,113	75,508	76,526	74,923	75,820	76,362	76,211	75,818
Goodwill	40,659	40,239	40,916	40,567	40,303	40,970	39,898	40,476	41,643	41,665	41,359
Intangible Assets	23,783	23,637	22,302	22,193	22,047	22,053	21,833	21,836	21,818	21,737	21,531
Other Noncurrent Operating Assets	11,830	12,079	12,248	12,353	13,158	13,503	13,192	13,508	12,901	12,809	12,928
Total Liabilities & Shareholders' Equity	120,829	122,531	120,709	119,598	122,370	126,482	122,639	122,984	127,599	127,286	128,378
Total Liabilities	73,764	74,517	71,880	69,264	71,811	74,341	71,195	70,439	74,048	73,969	73,647
Total Current Liabilities	35,756	37,158	35,950	32,340	33,627	36,420	33,797	34,248	37,995	36,699	38,235
Short-Term Debt	10,229	11,811	10,616	7,729	7,191	10,409	9,424	9,889	11,631	11,062	13,174
Accounts Payable	14,598	14,435	14,234	13,691	15,364	15,350	14,495	14,512	15,609	15,173	15,030
Accrued Expenses	10,929	10,912	11,100	10,921	11,073	10,661	9,879	9,847	10,756	10,463	10,031
Total Noncurrent Liabilities	38,008	37,360	35,929	36,923	38,183	37,921	37,399	36,191	36,052	37,270	35,412
Long-Term Debt	24,378	24,069	23,096	24,253	25,269	25,744	25,263	24,252	24,315	25,577	23,852
Noncurrent Deferred & Payable Income Tax Liabilities	6,478	6,814	6,219	6,284	6,516	6,420	6,725	6,481	5,893	5,974	6,047
Other Noncurrent Operating Liabilities	7,152	6,477	6,614	6,386	6,398	5,757	5,411	5,458	5,844	5,719	5,513
Total Equity & Noncontrolling Interests	47,065	48,014	48,829	50,333	50,559	52,141	51,443	52,545	53,551	53,317	54,731
Total Preferred & Common Equity	46,777	47,692	48,534	50,058	50,286	51,840	51,168	52,272	53,270	53,041	54,505
Preferred Stock	819	812	809	801	798	791	788	781	770	767	759
Total Common Equity	45,958	46,880	47,725	49,257	49,488	51,049	50,380	51,491	52,500	52,274	53,746
Common Stock	70,565	70,831	70,944	71,404	71,693	72,111	72,292	72,624	72,926	73,019	73,384
Retained Earnings	118,170	120,443	121,617	123,132	123,811	125,361	127,544	128,919	132,212	133,981	135,424
Treasury Stock	-129,736	-131,029	-131,887	-132,172	-133,379	-134,823	-137,112	-138,073	-139,845	-141,981	-142,168
Accumulated Other Comprehensive Income / (Loss)	-12,220	-12,583	-12,167	-12,370	-11,900	-10,893	-11,637	-11,307	-12,156	-12,108	-12,298
Other Equity Adjustments	-821	-782	-782	-737	-737	-707	-707	-672	-637	-637	-596
Noncontrolling Interest	288	321	294	275	272	300	275	273	281	276	226

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2,328,598,978.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2,328,598,978.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	6.89
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.70%	-0.37%	2.73%	1.27%	4.83%	7.28%	5.35%	2.27%	2.48%	0.29%	3.26%
EBITDA Growth	15.19%	-2.81%	0.29%	-44.08%	108.64%	8.61%	1.84%	1.54%	2.76%	6.07%	2.27%
EBIT Growth	19.82%	-1.56%	0.25%	-53.20%	153.92%	11.94%	1.72%	2.28%	2.19%	7.25%	1.06%
NOPAT Growth	21.24%	5.00%	-6.58%	-63.74%	262.47%	12.75%	-0.07%	-0.55%	1.64%	10.06%	-3.96%
Net Income Growth	48.43%	45.33%	-36.01%	-59.78%	230.38%	9.53%	3.07%	-0.37%	1.60%	7.29%	0.49%
EPS Growth	51.23%	51.49%	-34.35%	-61.04%	246.85%	10.89%	5.64%	1.55%	2.03%	8.14%	1.69%
Operating Cash Flow Growth	5.66%	-17.38%	16.58%	2.52%	14.18%	5.56%	-8.97%	0.75%	17.79%	-10.22%	9.76%
Free Cash Flow Firm Growth	-46.60%	-38.02%	12.11%	-13.08%	75.62%	-21.70%	1.26%	3.41%	19.73%	-14.26%	14.12%
Invested Capital Growth	-5.41%	2.62%	0.12%	-6.82%	-2.92%	4.49%	4.07%	3.22%	0.15%	5.03%	1.65%
Revenue Q/Q Growth	-0.69%	-0.04%	0.64%	0.88%	0.86%	1.67%	0.71%	1.28%	-0.03%	0.43%	0.36%
EBITDA Q/Q Growth	10.88%	0.53%	-3.54%	-44.28%	81.39%	-0.16%	0.43%	2.85%	-1.42%	2.66%	-1.96%
EBIT Q/Q Growth	13.36%	1.54%	-4.45%	-53.68%	114.05%	0.39%	0.43%	3.37%	-1.90%	3.23%	-2.66%
NOPAT Q/Q Growth	18.36%	2.00%	0.28%	-67.29%	165.85%	0.60%	0.87%	2.25%	-1.20%	2.11%	-2.47%
Net Income Q/Q Growth	15.46%	1.61%	-3.07%	-64.25%	157.93%	0.86%	1.02%	2.32%	-1.63%	3.09%	-3.27%
EPS Q/Q Growth	16.04%	2.38%	-2.39%	-66.03%	169.57%	1.29%	1.22%	2.79%	-1.63%	3.33%	-3.22%
Operating Cash Flow Q/Q Growth	0.99%	-3.42%	3.56%	-0.31%	3.91%	-3.59%	-2.38%	10.70%	2.13%	-4.14%	0.75%
Free Cash Flow Firm Q/Q Growth	-3.44%	-36.61%	69.44%	-11.93%	4.43%	-18.56%	14.45%	14.51%	5.61%	-9.21%	1.52%
Invested Capital Q/Q Growth	-4.94%	2.26%	-3.20%	-11.34%	-1.72%	2.42%	0.34%	-1.33%	-2.58%	-0.43%	-1.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.60%	49.83%	48.48%	48.63%	50.32%	51.25%	47.43%	47.86%	51.39%	51.16%	50.18%
EBITDA Margin	25.80%	25.16%	24.57%	13.57%	27.00%	27.34%	26.43%	26.24%	26.31%	27.83%	27.56%
Operating Margin	20.58%	21.16%	19.99%	8.11%	22.14%	23.63%	22.21%	22.11%	22.07%	24.26%	22.69%
EBIT Margin	21.08%	20.83%	20.33%	9.39%	22.75%	23.74%	22.93%	22.93%	22.86%	24.45%	23.93%
Profit (Net Income) Margin	16.24%	23.69%	14.75%	5.86%	18.47%	18.85%	18.45%	17.97%	17.82%	19.06%	18.55%
Tax Burden Percent	79.32%	116.25%	74.00%	65.35%	82.75%	81.48%	82.21%	80.30%	79.81%	79.66%	79.23%
Interest Burden Percent	97.12%	97.83%	98.09%	95.45%	98.08%	97.47%	97.89%	97.61%	97.65%	97.87%	97.85%
Effective Tax Rate	25.00%	23.10%	26.00%	34.65%	17.25%	18.52%	17.79%	19.70%	20.19%	20.34%	20.77%
Return on Invested Capital (ROIC)	13.92%	14.84%	13.68%	5.13%	19.57%	21.91%	21.00%	20.15%	20.14%	21.61%	20.09%
ROIC Less NNEP Spread (ROIC-NNEP)	18.32%	48.28%	13.53%	7.07%	20.13%	20.41%	21.65%	20.84%	20.84%	20.67%	22.12%
Return on Net Nonoperating Assets (RNNOA)	3.60%	12.25%	4.47%	2.76%	8.17%	8.78%	10.64%	11.24%	10.53%	9.63%	10.20%
Return on Equity (ROE)	17.52%	27.09%	18.15%	7.90%	27.74%	30.69%	31.64%	31.38%	30.68%	31.24%	30.29%
Cash Return on Invested Capital (CROIC)	19.48%	12.26%	13.56%	12.20%	22.54%	17.52%	17.01%	16.97%	19.99%	16.71%	18.46%
Operating Return on Assets (OROA)	10.73%	10.95%	11.38%	5.45%	13.69%	15.06%	15.54%	15.80%	15.80%	16.64%	16.54%
Return on Assets (ROA)	8.26%	12.45%	8.26%	3.40%	11.11%	11.96%	12.51%	12.38%	12.31%	12.98%	12.83%
Return on Common Equity (ROCE)	17.03%	26.31%	17.62%	7.67%	26.99%	29.90%	30.88%	30.64%	29.99%	30.60%	29.71%
Return on Equity Simple (ROE_SIMPLE)	18.49%	27.93%	18.86%	8.40%	28.22%	30.99%	31.75%	31.51%	29.78%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	10,081	10,585	9,888	3,586	12,997	14,654	14,643	14,562	14,802	16,291	15,646
NOPAT Margin	15.44%	16.27%	14.80%	5.30%	18.32%	19.25%	18.26%	17.76%	17.61%	19.33%	17.98%
Net Nonoperating Expense Percent (NNEP)	-4.40%	-33.44%	0.15%	-1.94%	-0.55%	1.50%	-0.65%	-0.69%	-0.70%	0.94%	-2.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	18.77%	17.69%
Cost of Revenue to Revenue	50.40%	50.17%	51.52%	51.37%	49.68%	48.75%	52.57%	52.14%	48.61%	48.84%	49.82%
SG&A Expenses to Revenue	29.02%	28.67%	28.48%	28.20%	28.18%	27.62%	25.21%	25.74%	27.73%	26.90%	27.49%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	29.02%	28.67%	28.48%	40.53%	28.18%	27.62%	25.21%	25.74%	29.33%	26.90%	27.49%
Earnings before Interest and Taxes (EBIT)	13,766	13,551	13,585	6,358	16,144	18,072	18,383	18,802	19,213	20,605	20,824
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16,844	16,371	16,419	9,182	19,157	20,807	21,190	21,516	22,109	23,452	23,984
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.23	3.43	3.29	5.28	5.91	6.78	7.12	7.54	7.82	7.24	6.36
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.79	2.85	2.53	3.61	3.80	4.05	4.06	4.23	4.60	4.40	3.89
Price to Earnings (P/E)	17.32	12.11	17.32	62.73	20.71	21.57	22.10	23.66	26.00	23.23	21.12
Dividend Yield	4.86%	3.72%	4.15%	2.97%	2.78%	2.57%	2.59%	2.50%	2.34%	2.58%	2.93%
Earnings Yield	5.77%	8.25%	5.77%	1.59%	4.83%	4.64%	4.53%	4.23%	3.85%	4.31%	4.73%
Enterprise Value to Invested Capital (EV/IC)	2.85	2.82	2.62	3.94	4.43	4.85	4.94	5.09	5.59	5.14	4.64
Enterprise Value to Revenue (EV/Rev)	3.08	3.13	2.84	3.92	4.08	4.35	4.38	4.56	4.89	4.71	4.18
Enterprise Value to EBITDA (EV/EBITDA)	11.93	12.44	11.56	28.92	15.11	15.92	16.57	17.39	18.59	16.93	15.18
Enterprise Value to EBIT (EV/EBIT)	14.60	15.03	13.97	41.77	17.94	18.33	19.10	19.90	21.39	19.27	17.49
Enterprise Value to NOPAT (EV/NOPAT)	19.93	19.25	19.20	74.06	22.28	22.61	23.98	25.69	27.76	24.37	23.27
Enterprise Value to Operating Cash Flow (EV/OCF)	13.02	15.97	12.77	17.42	16.64	18.03	21.00	22.20	20.71	22.28	18.62
Enterprise Value to Free Cash Flow (EV/FCFF)	14.24	23.30	19.37	31.17	19.35	28.27	29.60	30.49	27.98	31.52	25.33
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.57	0.59	0.63	0.74	0.69	0.67	0.74	0.64	0.66	0.63
Long-Term Debt to Equity	0.33	0.32	0.39	0.43	0.50	0.50	0.49	0.52	0.50	0.48	0.42
Financial Leverage	0.20	0.25	0.33	0.39	0.41	0.43	0.49	0.54	0.51	0.47	0.46
Leverage Ratio	2.12	2.18	2.20	2.32	2.50	2.57	2.53	2.53	2.49	2.41	2.36
Compound Leverage Factor	2.06	2.13	2.16	2.22	2.45	2.50	2.48	2.47	2.43	2.36	2.31
Debt to Total Capital	34.54%	36.16%	37.17%	38.74%	42.55%	40.68%	40.20%	42.37%	39.10%	39.76%	38.60%
Short-Term Debt to Total Capital	13.16%	15.51%	12.38%	12.48%	13.71%	11.30%	11.03%	12.52%	8.66%	10.96%	12.77%
Long-Term Debt to Total Capital	21.39%	20.65%	24.79%	26.26%	28.85%	29.37%	29.16%	29.85%	30.44%	28.80%	25.83%
Preferred Equity to Total Capital	1.17%	1.15%	1.15%	1.19%	0.98%	1.02%	1.08%	1.00%	0.96%	0.90%	0.85%
Noncontrolling Interests to Total Capital	0.72%	0.68%	0.70%	0.50%	0.44%	0.35%	0.34%	0.35%	0.33%	0.31%	0.26%
Common Equity to Total Capital	63.56%	62.01%	60.98%	59.57%	55.91%	57.87%	58.39%	56.27%	59.61%	59.03%	60.29%
Debt to EBITDA	1.82	1.93	1.91	3.28	1.81	1.54	1.49	1.61	1.47	1.47	1.42
Net Debt to EBITDA	1.02	1.01	1.18	2.16	0.97	1.04	1.15	1.23	1.04	1.06	1.01
Long-Term Debt to EBITDA	1.12	1.10	1.27	2.22	1.23	1.11	1.08	1.13	1.14	1.07	0.95
Debt to NOPAT	3.04	2.98	3.16	8.39	2.67	2.18	2.15	2.38	2.19	2.12	2.18
Net Debt to NOPAT	1.71	1.55	1.97	5.52	1.43	1.48	1.66	1.81	1.55	1.53	1.55
Long-Term Debt to NOPAT	1.88	1.70	2.11	5.69	1.81	1.58	1.56	1.67	1.71	1.53	1.46
Altman Z-Score	3.45	3.72	3.61	4.02	4.34	4.83	5.21	5.25	5.77	5.62	5.43
Noncontrolling Interest Sharing Ratio	2.80%	2.88%	2.91%	2.86%	2.72%	2.57%	2.41%	2.36%	2.23%	2.06%	1.91%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.10	0.88	0.83	0.75	0.85	0.70	0.65	0.63	0.73	0.70	0.68
Quick Ratio	0.58	0.65	0.59	0.51	0.13	0.45	0.16	0.38	0.46	0.44	0.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	14,106	8,743	9,802	8,521	14,964	11,717	11,864	12,269	14,690	12,595	14,374
Operating Cash Flow to CapEx	535.57%	453.36%	431.18%	516.15%	571.90%	669.25%	549.02%	558.62%	666.87%	486.01%	501.31%
Free Cash Flow to Firm to Interest Expense	24.36	18.80	19.37	16.74	32.18	23.34	27.03	16.23	15.88	13.89	16.39
Operating Cash Flow to Interest Expense	26.66	27.43	29.38	29.95	37.43	36.60	38.09	22.29	21.46	19.64	22.30
Operating Cash Flow Less CapEx to Interest Expense	21.68	21.38	22.57	24.14	30.88	31.13	31.15	18.30	18.24	15.60	17.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.53	0.56	0.58	0.60	0.63	0.68	0.69	0.69	0.68	0.69
Accounts Receivable Turnover	14.61	14.51	14.40	14.05	15.54	17.10	16.25	15.45	14.50	13.70	14.22
Inventory Turnover	6.79	6.99	7.36	7.13	6.70	6.46	6.53	6.11	5.80	5.65	5.52
Fixed Asset Turnover	3.35	3.31	3.30	3.23	3.38	3.59	3.74	3.81	3.81	3.66	3.53
Accounts Payable Turnover	3.77	3.44	3.45	3.22	3.02	2.88	2.95	2.90	2.73	2.69	2.75
Days Sales Outstanding (DSO)	24.99	25.15	25.34	25.98	23.48	21.35	22.46	23.62	25.17	26.64	25.67
Days Inventory Outstanding (DIO)	53.76	52.23	49.62	51.20	54.44	56.46	55.88	59.74	62.95	64.58	66.16
Days Payable Outstanding (DPO)	96.84	106.00	105.88	113.40	120.79	126.84	123.82	125.82	133.86	135.62	132.71
Cash Conversion Cycle (CCC)	-18.09	-28.62	-30.92	-36.21	-42.87	-49.03	-45.49	-42.46	-45.75	-44.41	-40.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	70,391	72,233	72,319	67,384	65,417	68,354	71,133	73,426	73,538	77,234	78,506
Invested Capital Turnover	0.90	0.91	0.92	0.97	1.07	1.14	1.15	1.13	1.14	1.12	1.12
Increase / (Decrease) in Invested Capital	-4,025	1,842	86	-4,935	-1,967	2,937	2,779	2,293	112	3,696	1,272
Enterprise Value (EV)	200,934	203,721	189,826	265,560	289,544	331,297	351,159	374,097	410,956	396,997	364,119
Market Capitalization	182,004	185,666	168,833	244,442	269,848	308,521	325,772	346,629	386,908	370,996	338,937
Book Value per Share	$21.15	$21.18	$20.41	$18.44	$18.43	$18.59	$19.07	$19.50	$20.97	$21.85	$22.90
Tangible Book Value per Share	($4.72)	($5.75)	($7.06)	($7.26)	($7.30)	($7.78)	($7.35)	($7.84)	($5.45)	($5.26)	($4.03)
Total Capital	88,581	87,370	84,169	77,671	81,598	78,642	78,347	81,672	83,019	86,792	88,449
Total Debt	30,598	31,592	31,286	30,092	34,720	31,988	31,493	34,607	32,460	34,508	34,138
Total Long-Term Debt	18,945	18,038	20,863	20,395	23,537	23,099	22,848	24,378	25,269	24,995	22,842
Net Debt	17,250	16,455	19,436	19,805	18,539	21,700	24,279	26,361	22,978	24,952	24,196
Capital Expenditures (CapEx)	2,882	2,813	3,448	2,953	3,043	2,745	3,046	3,016	2,976	3,666	3,901
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,317	-5,299	-6,344	-8,128	-9,987	-11,440	-9,997	-11,125	-11,209	-10,709	-11,132
Debt-free Net Working Capital (DFNWC)	14,665	9,838	5,506	2,159	6,194	-1,152	-2,783	-2,879	-1,727	-1,153	-1,190
Net Working Capital (NWC)	3,012	-3,716	-4,917	-7,538	-4,989	-10,041	-11,428	-13,108	-8,918	-10,666	-12,486
Net Nonoperating Expense (NNE)	-523	-4,826	27	-380	-106	302	-150	-176	-172	226	-498
Net Nonoperating Obligations (NNO)	12,408	16,455	19,436	19,805	18,539	21,700	24,279	26,361	22,979	24,950	24,195
Total Depreciation and Amortization (D&A)	3,078	2,820	2,834	2,824	3,013	2,735	2,807	2,714	2,896	2,847	3,160
Debt-free, Cash-free Net Working Capital to Revenue	2.02%	-8.15%	-9.49%	-12.01%	-14.08%	-15.03%	-12.47%	-13.57%	-13.34%	-12.71%	-12.79%
Debt-free Net Working Capital to Revenue	22.46%	15.12%	8.24%	3.19%	8.73%	-1.51%	-3.47%	-3.51%	-2.06%	-1.37%	-1.37%
Net Working Capital to Revenue	4.61%	-5.71%	-7.36%	-11.14%	-7.03%	-13.19%	-14.25%	-15.98%	-10.61%	-12.65%	-14.35%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.80	$5.80	$0.00	$1.45	$5.13	$5.69	$6.00	$6.07	$6.18	$6.67	$6.75
Adjusted Weighted Average Basic Shares Outstanding	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B	2.32B
Adjusted Diluted Earnings per Share	$3.69	$5.59	$0.00	$1.43	$4.96	$5.50	$5.81	$5.90	$6.02	$6.51	$6.62
Adjusted Weighted Average Diluted Shares Outstanding	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B	2.32B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B	2.32B
Normalized Net Operating Profit after Tax (NOPAT)	10,081	10,585	9,888	9,039	12,997	14,654	14,643	14,562	15,872	16,291	15,646
Normalized NOPAT Margin	15.44%	16.27%	14.80%	13.35%	18.32%	19.25%	18.26%	17.76%	18.89%	19.33%	17.98%
Pre Tax Income Margin	20.47%	20.38%	19.94%	8.97%	22.32%	23.14%	22.44%	22.38%	22.32%	23.93%	23.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	23.78	29.14	26.85	12.49	34.72	36.00	41.87	24.87	20.77	22.72	23.74
NOPAT to Interest Expense	17.41	22.76	19.54	7.04	27.95	29.19	33.36	19.26	16.00	17.96	17.84
EBIT Less CapEx to Interest Expense	18.80	23.09	20.03	6.69	28.17	30.53	34.94	20.88	17.55	18.68	19.30
NOPAT Less CapEx to Interest Expense	12.43	16.71	12.73	1.24	21.41	23.72	26.42	15.27	12.78	13.92	13.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	70.12%	46.95%	74.13%	189.06%	59.44%	57.57%	59.28%	61.06%	62.19%	61.45%	63.38%
Augmented Payout Ratio	107.88%	80.72%	145.16%	315.20%	115.96%	134.28%	126.90%	110.95%	95.62%	101.91%	94.52%

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	2,328,598,978.00	2,328,598,978.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	2,328,598,978.00	2,328,598,978.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	1.69	1.31
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.22%	0.63%	-0.10%	-0.61%	2.06%	-2.07%	1.74%	2.99%	1.49%	7.38%	1.50%
EBITDA Growth	-4.68%	6.11%	-6.28%	-9.54%	25.14%	0.48%	12.79%	15.31%	-5.14%	8.06%	-8.95%
EBIT Growth	-6.68%	6.62%	-8.56%	-11.12%	29.39%	1.02%	16.19%	16.80%	-7.36%	7.24%	-12.27%
NOPAT Growth	-12.10%	8.23%	-5.36%	-0.68%	32.84%	1.03%	10.66%	3.16%	-6.30%	-2.32%	-11.38%
Net Income Growth	-11.77%	10.43%	-7.31%	-12.49%	33.38%	0.32%	15.33%	19.91%	-7.04%	4.17%	-15.03%
EPS Growth	-11.95%	10.95%	-7.30%	-12.02%	34.29%	1.32%	16.54%	21.12%	-5.32%	5.84%	-14.86%
Operating Cash Flow Growth	42.70%	5.82%	7.73%	-12.28%	-5.39%	-9.37%	-13.36%	25.71%	3.05%	9.18%	2.93%
Free Cash Flow Firm Growth	824.26%	2,026.29%	192.14%	153.21%	115.61%	-37.36%	-106.67%	-2.77%	-68.34%	6.87%	997.58%
Invested Capital Growth	2.61%	1.44%	0.15%	2.67%	1.67%	2.76%	5.03%	2.88%	4.26%	2.43%	1.65%
Revenue Q/Q Growth	-1.97%	-5.81%	1.67%	5.87%	0.67%	-9.62%	5.63%	7.17%	-0.80%	-4.38%	-0.15%
EBITDA Q/Q Growth	-19.24%	1.89%	-12.65%	25.84%	11.72%	-18.18%	-1.94%	28.64%	-8.09%	-6.80%	-17.38%
EBIT Q/Q Growth	-21.85%	2.39%	-15.59%	31.60%	13.77%	-20.07%	-2.92%	32.30%	-9.76%	-7.47%	-20.58%
NOPAT Q/Q Growth	-23.95%	6.60%	-14.03%	42.50%	1.72%	-18.93%	-5.83%	32.84%	-7.61%	-15.49%	-14.56%
Net Income Q/Q Growth	-23.33%	8.25%	-16.85%	26.81%	16.85%	-18.59%	-4.40%	31.85%	-9.41%	-8.77%	-22.02%
EPS Q/Q Growth	-23.50%	8.57%	-16.45%	26.77%	16.77%	-18.09%	-3.90%	31.76%	-8.72%	-8.43%	-22.70%
Operating Cash Flow Q/Q Growth	4.00%	-19.84%	40.75%	-25.23%	12.16%	-23.21%	34.55%	8.49%	-8.06%	-18.64%	26.85%
Free Cash Flow Firm Q/Q Growth	55.10%	68.35%	17.12%	-17.20%	32.07%	-51.09%	-112.48%	1,306.55%	-56.99%	65.08%	4.79%
Invested Capital Q/Q Growth	0.66%	1.12%	-2.58%	3.53%	-0.31%	2.20%	-0.43%	1.41%	1.03%	0.40%	-1.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.69%	51.20%	49.60%	52.06%	52.39%	50.98%	49.11%	51.37%	51.22%	49.51%	48.50%
EBITDA Margin	24.86%	26.90%	23.11%	27.47%	30.49%	27.60%	25.62%	30.76%	28.49%	27.77%	22.98%
Operating Margin	20.68%	22.08%	18.92%	26.67%	26.24%	23.05%	20.85%	26.16%	24.16%	21.55%	18.63%
EBIT Margin	21.50%	23.37%	19.40%	24.12%	27.26%	24.11%	22.16%	27.36%	24.88%	24.08%	19.15%
Profit (Net Income) Margin	16.29%	18.72%	15.31%	18.34%	21.29%	19.18%	17.36%	21.36%	19.50%	18.61%	14.53%
Tax Burden Percent	77.69%	82.34%	81.22%	77.57%	79.71%	81.38%	80.20%	79.23%	79.89%	79.19%	78.34%
Interest Burden Percent	97.53%	97.29%	97.16%	98.04%	97.99%	97.76%	97.67%	98.53%	98.10%	97.57%	96.85%
Effective Tax Rate	22.31%	17.68%	18.75%	22.41%	20.31%	18.62%	19.80%	20.77%	20.11%	20.83%	21.64%
Return on Invested Capital (ROIC)	18.29%	20.39%	17.58%	23.10%	23.43%	20.57%	18.69%	22.79%	21.23%	18.85%	16.32%
ROIC Less NNEP Spread (ROIC-NNEP)	18.47%	20.79%	17.53%	21.07%	23.76%	20.90%	19.25%	23.37%	21.41%	20.16%	16.26%
Return on Net Nonoperating Assets (RNNOA)	10.63%	11.76%	8.86%	10.55%	11.91%	10.20%	8.97%	10.79%	10.27%	9.35%	7.50%
Return on Equity (ROE)	28.93%	32.15%	26.44%	33.65%	35.34%	30.76%	27.67%	33.58%	31.51%	28.20%	23.81%
Cash Return on Invested Capital (CROIC)	17.37%	18.56%	19.99%	17.04%	19.49%	18.13%	16.71%	18.42%	16.64%	18.03%	18.46%
Operating Return on Assets (OROA)	15.14%	16.41%	13.41%	16.25%	18.90%	16.68%	15.09%	18.29%	16.98%	16.61%	13.24%
Return on Assets (ROA)	11.47%	13.15%	10.58%	12.36%	14.76%	13.27%	11.82%	14.28%	13.31%	12.84%	10.05%
Return on Common Equity (ROCE)	28.24%	31.42%	25.85%	32.90%	34.58%	30.13%	27.10%	32.90%	30.87%	27.66%	23.36%
Return on Equity Simple (ROE_SIMPLE)	30.63%	30.41%	0.00%	27.79%	30.43%	29.81%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	3,444	3,671	3,156	4,498	4,575	3,709	3,493	4,640	4,287	3,623	3,095
NOPAT Margin	16.06%	18.18%	15.37%	20.69%	20.91%	18.76%	16.72%	20.73%	19.30%	17.06%	14.60%
Net Nonoperating Expense Percent (NNEP)	-0.18%	-0.41%	0.05%	2.04%	-0.33%	-0.33%	-0.56%	-0.58%	-0.17%	-1.32%	0.06%
Return On Investment Capital (ROIC_SIMPLE)	4.17%	-	-	-	5.31%	4.28%	4.02%	5.18%	4.77%	3.95%	3.50%
Cost of Revenue to Revenue	47.31%	48.80%	50.40%	47.94%	47.61%	49.02%	50.89%	48.63%	48.78%	50.49%	51.50%
SG&A Expenses to Revenue	25.75%	29.12%	30.68%	25.39%	26.15%	27.93%	28.26%	25.21%	27.05%	27.95%	29.88%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.01%	29.12%	30.68%	25.39%	26.15%	27.93%	28.26%	25.21%	27.05%	27.95%	29.88%
Earnings before Interest and Taxes (EBIT)	4,610	4,720	3,984	5,243	5,965	4,768	4,629	6,124	5,526	5,113	4,061
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,331	5,432	4,745	5,971	6,671	5,458	5,352	6,885	6,328	5,898	4,873
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.06	7.70	7.82	7.94	7.84	7.71	7.24	6.81	6.36	6.20	6.36
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.02	4.51	4.60	4.83	4.68	4.73	4.40	4.21	3.90	3.84	3.89
Price to Earnings (P/E)	22.82	25.08	26.00	28.31	25.51	25.63	23.23	21.32	20.21	20.05	21.12
Dividend Yield	2.61%	2.33%	2.34%	2.26%	2.36%	2.38%	2.58%	2.70%	2.94%	2.95%	2.93%
Earnings Yield	4.38%	3.99%	3.85%	3.53%	3.92%	3.90%	4.31%	4.69%	4.95%	4.99%	4.73%
Enterprise Value to Invested Capital (EV/IC)	4.87	5.37	5.59	5.65	5.54	5.46	5.14	4.89	4.54	4.52	4.64
Enterprise Value to Revenue (EV/Rev)	4.34	4.82	4.89	5.13	4.98	5.04	4.71	4.51	4.22	4.14	4.18
Enterprise Value to EBITDA (EV/EBITDA)	16.46	18.08	18.59	20.04	18.42	18.53	16.93	15.73	14.96	14.67	15.18
Enterprise Value to EBIT (EV/EBIT)	18.86	20.71	21.39	23.19	21.11	21.20	19.27	17.84	17.07	16.78	17.49
Enterprise Value to NOPAT (EV/NOPAT)	24.76	27.07	27.76	29.11	26.40	26.53	24.37	23.34	22.28	22.37	23.27
Enterprise Value to Operating Cash Flow (EV/OCF)	18.95	20.87	20.71	22.37	22.16	22.77	22.28	20.25	18.85	18.49	18.62
Enterprise Value to Free Cash Flow (EV/FCFF)	28.43	29.16	27.98	33.61	28.65	30.51	31.52	26.94	27.87	25.35	25.33
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.69	0.64	0.64	0.69	0.67	0.65	0.66	0.67	0.69	0.68	0.63
Long-Term Debt to Equity	0.47	0.48	0.50	0.49	0.49	0.46	0.48	0.45	0.48	0.44	0.42
Financial Leverage	0.58	0.57	0.51	0.50	0.50	0.49	0.47	0.46	0.48	0.46	0.46
Leverage Ratio	2.55	2.50	2.49	2.49	2.43	2.36	2.41	2.40	2.39	2.34	2.36
Compound Leverage Factor	2.49	2.43	2.42	2.44	2.38	2.31	2.35	2.37	2.34	2.29	2.29
Debt to Total Capital	40.84%	38.85%	39.10%	40.95%	40.27%	39.38%	39.76%	40.16%	40.73%	40.35%	38.60%
Short-Term Debt to Total Capital	12.86%	9.39%	8.66%	11.79%	10.94%	11.41%	10.96%	13.00%	12.30%	14.36%	12.77%
Long-Term Debt to Total Capital	27.98%	29.46%	30.44%	29.16%	29.33%	27.98%	28.80%	27.17%	28.43%	25.99%	25.83%
Preferred Equity to Total Capital	0.98%	0.97%	0.96%	0.90%	0.91%	0.90%	0.90%	0.86%	0.85%	0.83%	0.85%
Noncontrolling Interests to Total Capital	0.36%	0.33%	0.33%	0.34%	0.32%	0.31%	0.31%	0.31%	0.31%	0.25%	0.26%
Common Equity to Total Capital	57.82%	59.84%	59.61%	57.82%	58.49%	59.40%	59.03%	58.66%	58.11%	58.57%	60.29%
Debt to EBITDA	1.52	1.43	1.47	1.68	1.52	1.49	1.47	1.48	1.53	1.51	1.42
Net Debt to EBITDA	1.17	1.12	1.04	1.12	1.07	1.10	1.06	1.02	1.07	1.01	1.01
Long-Term Debt to EBITDA	1.04	1.08	1.14	1.20	1.11	1.06	1.07	1.00	1.06	0.98	0.95
Debt to NOPAT	2.29	2.13	2.19	2.45	2.18	2.14	2.12	2.19	2.27	2.31	2.18
Net Debt to NOPAT	1.76	1.68	1.55	1.62	1.54	1.57	1.53	1.51	1.60	1.54	1.55
Long-Term Debt to NOPAT	1.57	1.62	1.71	1.74	1.59	1.52	1.53	1.48	1.59	1.49	1.46
Altman Z-Score	4.92	5.46	5.36	5.37	5.55	5.57	5.20	5.07	4.89	4.90	4.99
Noncontrolling Interest Sharing Ratio	2.36%	2.28%	2.23%	2.22%	2.16%	2.07%	2.06%	2.03%	2.01%	1.90%	1.91%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.64	0.69	0.73	0.75	0.76	0.71	0.70	0.71	0.72	0.73	0.68
Quick Ratio	0.18	0.40	0.46	0.51	0.49	0.45	0.44	0.46	0.47	0.49	0.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,544	2,599	3,044	2,521	3,329	1,628	-203	2,451	1,054	1,740	1,823
Operating Cash Flow to CapEx	628.08%	561.54%	1,119.46%	453.80%	522.75%	440.02%	523.09%	453.69%	428.99%	757.49%	505.02%
Free Cash Flow to Firm to Interest Expense	6.23	11.16	13.90	10.59	13.87	7.50	-0.96	12.44	4.79	7.80	7.69
Operating Cash Flow to Interest Expense	20.56	17.55	26.27	18.08	20.10	17.07	23.51	27.45	22.60	18.14	21.65
Operating Cash Flow Less CapEx to Interest Expense	17.29	14.42	23.93	14.09	16.26	13.19	19.02	21.40	17.33	15.74	17.36
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.70	0.70	0.69	0.67	0.69	0.69	0.68	0.67	0.68	0.69	0.69
Accounts Receivable Turnover	13.87	14.50	14.50	13.39	13.42	13.69	13.70	13.27	13.63	13.92	14.22
Inventory Turnover	5.67	5.65	5.80	5.66	5.79	5.65	5.65	5.50	5.67	5.65	5.52
Fixed Asset Turnover	3.88	3.86	3.81	3.80	3.82	3.75	3.66	3.64	3.66	3.67	3.53
Accounts Payable Turnover	2.94	2.99	2.73	2.74	2.86	2.90	2.69	2.69	2.83	2.92	2.75
Days Sales Outstanding (DSO)	26.31	25.17	25.17	27.25	27.19	26.67	26.64	27.51	26.78	26.22	25.67
Days Inventory Outstanding (DIO)	64.36	64.64	62.95	64.48	63.02	64.63	64.58	66.35	64.40	64.63	66.16
Days Payable Outstanding (DPO)	124.35	121.99	133.86	133.33	127.75	125.90	135.62	135.72	128.77	125.17	132.71
Cash Conversion Cycle (CCC)	-33.67	-32.18	-45.75	-41.60	-37.54	-34.60	-44.41	-41.86	-37.58	-34.32	-40.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74,653	75,488	73,538	76,137	75,899	77,569	77,234	78,326	79,132	79,452	78,506
Invested Capital Turnover	1.14	1.12	1.14	1.12	1.12	1.10	1.12	1.10	1.10	1.10	1.12
Increase / (Decrease) in Invested Capital	1,900	1,072	112	1,977	1,246	2,081	3,696	2,189	3,233	1,883	1,272
Enterprise Value (EV)	363,917	405,560	410,956	430,428	420,343	423,214	396,997	383,233	359,374	358,876	364,119
Market Capitalization	336,992	379,330	386,908	405,340	394,823	397,135	370,996	357,407	332,517	333,171	338,937
Book Value per Share	$20.25	$20.93	$20.97	$21.69	$21.39	$21.96	$21.85	$22.41	$22.37	$23.13	$22.90
Tangible Book Value per Share	($6.57)	($5.74)	($5.45)	($5.09)	($4.82)	($4.61)	($5.26)	($4.68)	($4.76)	($3.93)	($4.03)
Total Capital	82,541	82,315	83,019	88,294	86,130	86,686	86,792	89,497	89,956	91,757	88,449
Total Debt	33,712	31,982	32,460	36,153	34,687	34,141	34,508	35,946	36,639	37,026	34,138
Total Long-Term Debt	23,096	24,253	25,269	25,744	25,263	24,252	24,995	24,315	25,577	23,852	22,842
Net Debt	25,822	25,154	22,978	23,997	24,457	25,025	24,952	24,775	25,814	24,720	24,196
Capital Expenditures (CapEx)	812	728	514	948	923	842	953	1,192	1,159	534	1,016
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-10,113	-8,981	-11,209	-10,718	-8,961	-9,040	-10,709	-10,417	-9,874	-9,380	-11,132
Debt-free Net Working Capital (DFNWC)	-2,223	-2,153	-1,727	1,438	1,269	76	-1,153	754	951	2,926	-1,190
Net Working Capital (NWC)	-12,839	-9,882	-8,918	-8,971	-8,155	-9,813	-10,666	-10,877	-10,111	-10,248	-12,486
Net Nonoperating Expense (NNE)	-49	-110	12	511	-84	-84	-133	-141	-44	-328	14
Net Nonoperating Obligations (NNO)	25,824	25,155	22,979	23,996	24,456	25,024	24,950	24,775	25,815	24,721	24,195
Total Depreciation and Amortization (D&A)	721	712	761	728	706	690	723	761	802	785	812
Debt-free, Cash-free Net Working Capital to Revenue	-12.05%	-10.68%	-13.34%	-12.77%	-10.62%	-10.77%	-12.71%	-12.27%	-11.58%	-10.82%	-12.79%
Debt-free Net Working Capital to Revenue	-2.65%	-2.56%	-2.06%	1.71%	1.50%	0.09%	-1.37%	0.89%	1.12%	3.37%	-1.37%
Net Working Capital to Revenue	-15.30%	-11.76%	-10.61%	-10.69%	-9.67%	-11.69%	-12.65%	-12.81%	-11.86%	-11.82%	-14.35%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.44	$1.56	$1.29	$1.65	$1.94	$1.58	$1.50	$2.00	$1.82	$1.66	$1.27
Adjusted Weighted Average Basic Shares Outstanding	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B	2.32B
Adjusted Diluted Earnings per Share	$1.40	$1.52	$1.27	$1.61	$1.88	$1.54	$1.48	$1.95	$1.78	$1.63	$1.26
Adjusted Weighted Average Diluted Shares Outstanding	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B	2.32B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B	2.32B
Normalized Net Operating Profit after Tax (NOPAT)	4,486	3,671	3,156	4,498	4,575	3,709	3,493	4,640	4,287	3,623	3,095
Normalized NOPAT Margin	20.92%	18.18%	15.37%	20.69%	20.91%	18.76%	16.72%	20.73%	19.30%	17.06%	14.60%
Pre Tax Income Margin	20.97%	22.74%	18.85%	23.65%	26.71%	23.57%	21.64%	26.95%	24.41%	23.49%	18.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	18.59	20.26	18.19	22.03	24.85	21.97	21.83	31.09	25.12	22.93	17.14
NOPAT to Interest Expense	13.89	15.76	14.41	18.90	19.06	17.09	16.48	23.55	19.49	16.25	13.06
EBIT Less CapEx to Interest Expense	15.31	17.13	15.84	18.05	21.01	18.09	17.34	25.04	19.85	20.53	12.85
NOPAT Less CapEx to Interest Expense	10.61	12.63	12.07	14.91	15.22	13.21	11.98	17.50	14.22	13.85	8.77
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	61.16%	60.12%	62.19%	65.72%	61.78%	62.68%	61.45%	59.17%	60.97%	60.97%	63.38%
Augmented Payout Ratio	87.08%	83.05%	95.62%	103.52%	106.43%	109.63%	101.91%	93.64%	94.72%	90.05%	94.52%

Financials Breakdown Chart

Key Financial Trends

Procter & Gamble’s recent results show resilient cash generation, but weaker profitability in the latest quarter. Q4 fiscal 2026 revenue was $21.2 billion, broadly stable with Q3 and up from $20.9 billion in Q4 fiscal 2025 and $19.5 billion in Q4 fiscal 2022. However, revenue has eased from $22.4 billion in Q1 fiscal 2026, suggesting that near-term growth remains uneven.

Profitability was the main concern. Q4 fiscal 2026 operating income fell to $3.95 billion from $4.58 billion in Q3 and $4.36 billion in Q4 fiscal 2025. The operating margin declined to approximately 18.6%, as selling, general and administrative expense increased to $6.34 billion, or nearly 30% of revenue. Net income attributable to common shareholders fell to $3.05 billion, while diluted earnings per share declined to $1.26 from $1.48 in the prior-year quarter.

Cash flow remains a meaningful strength. Operating cash flow reached $5.13 billion in Q4 fiscal 2026, exceeding reported net income and producing approximately $4.1 billion of cash flow after capital expenditures. P&G used that cash to pay $2.61 billion in dividends, repurchase $875 million of stock and repay $3.01 billion of debt. At the end of Q3 fiscal 2026, cash and equivalents stood at $12.3 billion, although total debt of approximately $37.0 billion and current liabilities of $38.2 billion remained substantial relative to current assets of $28.0 billion.

Strong operating cash generation: Q4 fiscal 2026 operating cash flow of $5.13 billion was higher than the $4.99 billion generated in Q4 fiscal 2025 and comfortably exceeded quarterly net income.
Healthy cash conversion: Capital expenditures of $1.02 billion imply approximately $4.1 billion of quarterly operating free cash flow before other uses, supporting dividends, buybacks and debt reduction.
Long-term revenue expansion: Quarterly revenue increased from $19.5 billion in Q4 fiscal 2022 to $21.2 billion in Q4 fiscal 2026, despite recent sequential volatility.
Shareholder distributions remain substantial: P&G paid $2.61 billion in dividends and repurchased $875 million of common stock in the latest quarter, supporting income-oriented investors and per-share value over time.
Debt repayment continued: The company repaid $3.01 billion of debt in Q4 fiscal 2026, following larger repayments in earlier fiscal 2026 quarters.
Balance sheet assets have expanded: Total assets reached $128.4 billion at the end of Q3 fiscal 2026, up from $122.4 billion at the end of fiscal 2024, but much of the asset base consists of goodwill and intangible assets.
Share count is gradually declining: Weighted average diluted shares fell to approximately 2.32 billion in Q4 fiscal 2026 from 2.34 billion in Q4 fiscal 2025, although the reduction has been modest.
Latest-quarter earnings weakened: Net income attributable to common shareholders declined approximately 16% year over year, and diluted EPS dropped from $1.48 to $1.26.
Operating expenses pressured margins: Q4 fiscal 2026 SG&A expense increased approximately 7% year over year while revenue rose only about 2%, contributing to lower operating income and margin compression.
Liquidity remains tight on a current basis: Q3 fiscal 2026 current assets of $28.0 billion were below current liabilities of $38.2 billion, indicating reliance on ongoing operating cash flow and access to financing to meet short-term obligations.

08/18/26 01:41 AM ETAI Generated. May Contain Errors.

Procter & Gamble Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Procter & Gamble's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Procter & Gamble's net income appears to be on an upward trend, with a most recent value of $16.14 billion in 2026, rising from $10.60 billion in 2016. The previous period was $16.07 billion in 2025. Find out what analysts predict for Procter & Gamble in the coming months.

Procter & Gamble's total operating income in 2026 was $19.75 billion, based on the following breakdown:

Total Gross Profit: $43.67 billion
Total Operating Expenses: $23.92 billion

Over the last 10 years, Procter & Gamble's total revenue changed from $65.30 billion in 2016 to $87.03 billion in 2026, a change of 33.3%.

Procter & Gamble's total liabilities were at $72.21 billion at the end of 2026, a 1.0% decrease from 2025, and a 4.4% increase since 2016.

In the past 10 years, Procter & Gamble's cash and equivalents has ranged from $0.00 in 2020 to $10.29 billion in 2021, and is currently $9.94 billion as of their latest financial filing in 2026.

Over the last 10 years, Procter & Gamble's book value per share changed from 21.15 in 2016 to 22.90 in 2026, a change of 8.3%.

Related Companies

Financial statements for NYSE:PG last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Procter & Gamble (PG) Financials

Financials Breakdown Chart

Key Financial Trends

Procter & Gamble Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Procter & Gamble (PG) Financials

Annual Income Statements for Procter & Gamble

Quarterly Income Statements for Procter & Gamble

Annual Cash Flow Statements for Procter & Gamble

Quarterly Cash Flow Statements for Procter & Gamble

Annual Balance Sheets for Procter & Gamble

Quarterly Balance Sheets for Procter & Gamble

Annual Metrics And Ratios for Procter & Gamble

Quarterly Metrics And Ratios for Procter & Gamble

Financials Breakdown Chart

Key Financial Trends

Procter & Gamble Financials - Frequently Asked Questions

When does Procter & Gamble's fiscal year end?

How has Procter & Gamble's net income changed over the last 10 years?

What is Procter & Gamble's operating income?

How has Procter & Gamble's revenue changed over the last 10 years?

How much debt does Procter & Gamble have?

How much cash does Procter & Gamble have?

How has Procter & Gamble's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools